The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor pqip exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models

Sara A. Flanigan, Todd M. Pitts, S. Gail Eckhardt, John J. Tentler, Aik Choon Tan, Andrew Thorburn, Stephen Leong

Research output: Contribution to journal › Article › peer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor pqip exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models'. Together they form a unique fingerprint.

Medicine & Life Sciences